1 |
Toris CB, Alm A, Camras CB. Latanoprost and cholinergic agonists in combination. Surv Ophthalmol 2002; 47: S141-7.
|
2 |
Zhang X, Wang N, Schroeder A, et al. Expression of adenylate cyclase subtypes Ⅱ and Ⅳ in the human outflow pathway. Invest Ophathalmol Vis Sci 2000; 41: 998-1005.
|
3 |
Schachtschabel U, Lindsey JD, Weinreb RN. The mechanism of action of prostaglandins on uveoscleral outflow. Curr Opin Ophthalmol 2000; 11: 112-5.
|
4 |
Wu LL, Huang P, Gao YX, et al. A 12-week, double-masked, parallel-group study of the safety and efficacy of travoprost 0.004% compared with pilocarpine 1% in Chinese patients with primary angle-closure and primary angle-closure glaucoma. J Glaucoma 2011; 20: 388-91.
|
5 |
Diestelhorst M. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. A 6-month, randomized, multicenter study. German Latanoprost Study Group. Graefes Arch Clin Exp Ophthalmol 2000; 238: 433-9.
|
6 |
Toor A, Chanis RA, Polikoff LA, et al. Additivity of pilocarpine to bimatoprost in ocular hypertension and early glaucoma. J Glaucoma 2005; 14: 243-8.
|
7 |
Kent AR, Vroman DT, Thomas TJ, et al. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. J Glaucoma 1999; 8: 257-62.
|
8 |
Kaufman PL. Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophy- siology of presbyopia interrogating Mother Nature: Asking why, asking how, recognizing the signs, following the trail. Exp Eye Res 2008; 86: 3-17.
|
9 |
Lan YQ, Zhang C, Xiao JH, et al. Suppression of IkappaBalpha increases the expression of matrix metallo- proteinase-2 in human ciliary muscle cells. Mol Vis 2009; 26; 15: 1977-87.
|
1 |
0.Zhong Y, Gao J, Ye W, et al. Effect of latanoprost acid and pilocarpine on cultured rabbit ciliary muscle cells. Ophthalmic Res 2007; 39: 232-40.
|
|
1.Lindsey JD, Crowston JG, Tran A, et al. Direct matrix metalloproteinase enhancement of transscleral permeability. Invest Ophthalmol Vis Sci 2007; 48: 752-5.
|
|
2.Zhang SH, Zhao JL, Liu XL, et al. Pilot study on hypotensive effect of combination of 0.004% travoprost with 2% pilocarpine on normal albino rabbits. Chin J Exp Ophthalmol 2012; 9: 774-8.
|
|
3.Kaplan-Messas A, Naveh N, Avni I, et al. Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye. Eur J Ophthalmol 2003; 13: 18-23.
|